Interactions of aluminum nanoparticles with human epidermal keratinocytes

Journal of Applied Toxicology

Volumn 30, Issue 3, 2010, Pages 276-285

  Monteiro Riviere, Nancy A ^a   Oldenburg, Steven J ^b   Inman, Alfred O ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NanoComposix   (United States)

Author keywords

Aluminum; Cytokine; Human epidermal keratinocytes; Nanoparticles; Nanotoxicity; Viability assays

Indexed keywords

ALUMINUM; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; METAL NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EPIDERMIS CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; TRANSMISSION ELECTRON MICROSCOPY;

ALUMINUM; ARTIFACTS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INDICATORS AND REAGENTS; INFLAMMATION MEDIATORS; KERATINOCYTES; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; OSMOLAR CONCENTRATION; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY; TEMPERATURE; VACUOLES;

EID: 77951545351     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1494     Document Type: Article

References (34)

1. Burrows D, Adams RM, Flint GN. 1999. Metals. In Occupational Skin Disease, Adams RM (ed.) WB Saunders Company: Philadelphia, PA; 395-433.
2. Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G. 2007. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45: 1425-1432. (Pubitemid 46829030)
3. 3) nanoparticles in mouse skin epithelial cells. Carcinogen 29: 1920-1929.
4. Di Virgilio AL, Reigosa M, de Mele MFL. 2009. Response of UMR 106 cells exposed to titanium oxide and aluminum oxide nanoparticles. J. Biomed. Mater. Res. A. Early view in advance of print. DOI: 10.1002/jbm.a.32339.
5. Exley C. 2004. The pro-oxidant activity of aluminum. Free Radic. Biol. Med. 36: 380-387.
6. Exley C, Charles LM, Barr L, Martin C, Polwart A, Darbre PD. 2007. Aluminium in human breast tissue. J. Inorg. Biochem. 101: 1344-1346.
7. Flaten TP. 2001. Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res. Bull. 55: 187-196. (Pubitemid 32722158)
8. Gutwein LG, Webster TJ. 2004. Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titania particles. Biomater. 25: 4175-4183.
9. Horie M, Nishio K, Fujita K, Endoh S, Miyauchi A, Saito Y, Iwahashi H, Yamamoto K, Murayama H, Nakano H, Nanashima N, Niki E, Yoshida Y. 2009. Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem. Res. Toxicol. 22: 543-553.
10. Hunley JD. 1999. The history of solid-propellant rocketry: what we do and do not know. American Institute of Aeronautics and Astronautics. Presented as an invited paper at the 35th AIAA, ASME, SAE, ASEE Joint Propulsion Conference and Exhibition.
11. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. in Vitro 19: 975-983.
12. 60 toxicity in human epidermal keratinocytes. Toxicol. CD Offic. J. Soc. Toxicol. 90(S-1): 167.
13. Loney D. 2004. Weapons that tread lightly. The Website of the American Chemical Society. Available from: http://www.chemistry.org/portal/a/c/s/1/ feature-ent.html?id=c373e9fb05781bca 8f6a4fd8fe800100.2004 (accessed 23 May 2007).
14. McCormack-Brown S. 2008. In vitro toxicity of aluminum nanoparticles in human keratinocytes. Master's Thesis. Air Force Institute of Technology, Air University.
15. Miziolek A. 2002. Nanoenergetics: an emerging technology area of national importance. AMPTIAC Q. 6(1): 43-48.
16. Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44: 1070-1078.
17. Monteiro-Riviere NA, Tran CL. 2007. Nanotoxicology: Characterization, Dosing, and Health Effects. Informa Healthcare: New York.
18. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. 2005. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 155: 377-384. (Pubitemid 40093001)
19. Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234: 222-235.
20. Oesterling E, Chopra N, Gavalas V, Arzuga X, Lim EJ, Sultana R, Butterfield DA, Bachas L, Hennig B. 2008. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol. Lett. 178: 160-166.
21. Palaszewski, BA. 2002. Nanotechnology investigated for future gelled and metallized gelled fuels. Available from: http://www.grc.nasa.gov/WWW/RT2002/ 5000/5830palaszewski1.html (accessed 23 May 2007).
22. Rodrigo A, Vallés G, Saldaña L, Rodríguez M, Martínez ME, Munuera L, Vilaboa N. 2006. Alumina particles influence the interactions of cocultured osteoblasts and macrophages. J. Orthrop. Res. 24: 46-54. (Pubitemid 43772607)
23. Rooney AD, Jones RL, Mattie DR, Schlager JJ, Hussain SM. 2004. In vitro toxicity of nanoparticles in mouse keratinocytes and endothelial cells. United States Air Force Research Laboratory. AFRL-HE-WP-TR-2005-10091
24. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. 2006. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol. in Vitro 20: 1313-1320. (Pubitemid 44537654)
25. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2007. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J. Invest. Dermatol. 127: 143-153.
26. Samberg ME, Siekkinen AR, Oldenburg SJ, Monteiro-Riviere NA. 2009. Assessment of silver nanoparticles in human epidermal keratinocytes and in vivo pig skin. Toxicol. CD Offic. J. Soc. Toxicol. 108(S-1): 182.
27. Simon-Deckers A, Gouget B, Mayne-L'Hermite M, Herlin-Boime N, Reynaud C, Carrière M. 2008. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253: 137-146.
28. Tyner KM, Schiffman SR, Giannelis EP. 2004. Nanobiohybrids as delivery vehicles for camptothecin. J. Cont. Rel. 95: 501-514.
29. Wagner AJ, Bleckmann CA, Murdock RC, Schrand AM, Schlager JJ, Hussain SM. 2007. Cellular interaction of different forms of aluminum nanoparticles in rat alveolar macrophages. J. Phys Chem B 111: 7353-7359.
30. Wörle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! carbon nanotubes hoax scientists in viability assays. Nano Lett. 6: 1261-1268. (Pubitemid 44013492)
31. Yang L, Watts DJ. 2005. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol. Lett. 158: 122-132. (Pubitemid 41019350)
32. Yokel RA, McNamara PJ. 2001. Aluminium toxicokinetics: an updated mini review. Pharm. Toxicol. 88: 159-167.
33. Zhang LW, Zeng L, Barron AR, Monteiro-Riviere NA. 2007. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int. J. Toxicol. 26: 103-113. (Pubitemid 46514921)
34. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. 2008. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 228: 200-211.